HPMA-gemcitabine

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHPMA-gemcitabine
Drug Alias NameRX-21202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulatorsMitosis inhibitorsTubulin polymerisation promoters
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRexahn Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRexahn Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A